痛泻要方加味治疗肝郁脾虚腹泻型肠易激综合征临床观察OACSTPCD
Clinical Observation of Modified Tongxieyao Formula for Liver Depression and Spleen Deficiency Type Diarrhea Predominant Irritable Bowel Syndrome
目的:观察痛泻要方加味方治疗肝郁脾虚腹泻型肠易激综合征的临床效果及不良反应,并与匹维溴铵联合蒙脱石散的疗效进行比较.方法:将确诊的74例肝郁脾虚腹泻型肠易激综合征患者采用完全随机分为2组,治疗组36例,对照组38例,治疗组以痛泻要方加味方治疗,对照组用匹维溴铵联合蒙脱石散治疗,疗程均为4周,比较2组患者的症状改善、临床疗效及复发率.结果:治疗后2组患者在腹泻、腹痛、急躁易怒、食少纳差症状改善以及综合疗效方面,治疗组均优于对照组,差异有统计学意义(…查看全部>>
Objective:To observe the clinical efficacy and adverse effect of Modified Tongxieyao Formula for diarrhea predominant irritable bowel syndrome (IBS-D) of liver depression and spleen deficiency pattern,and comparing the effect of combining Pinaverium Bromide and Montmorillonite Powder.Methods:74 patients diagnosed with IBS-D of liver depression and spleen deficiency pattern were randomly divided into two groups,36 in treatment group and 38 in controlled group…查看全部>>
王建国;杜勇军;黄粲宸;周策;袁可;余乐来;陈敏;黄德铨
乐山市人民医院,四川乐山614000成都中医药大学附属医院,四川成都610072西南医科大学,四川泸州646000成都中医药大学附属医院,四川成都610072乐山市人民医院,四川乐山614000乐山市人民医院,四川乐山614000成都中医药大学附属医院,四川成都610072成都中医药大学附属医院,四川成都610072
医药卫生
腹泻型肠易激综合征肝郁脾虚证痛泻要方疗效观察
Diarrhea predominant irritable bowel syndrome (IBS-D)Liver depression and spleen deficiency patternTongxieyao FormulaCurattive observation
《四川中医》 2017 (6)
155-157,3
国家自然科学基金面上项目(No.81373644):基于脑肠轴双向调节假说研究痛泻要方抑木组分白芍防风缓解IBS-D内脏高敏的机制四川省中医药管理局项目(NO.2016C075):等离子体手术系统结合中药熏洗治疗高位单纯性肛瘘的多中心临床随机对照研究.
评论